Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elba Raimúndez

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Iscience|October 23, 2023
Posterior marginalization accelerates Bayesian inference for dynamical models of biological processesElba Raimúndez, Michael Fedders, Jan Hasenauer
Bioinformatics (Oxford, England)|January 10, 2019
Benchmark problems for dynamic modeling of intracellular processesHelge Hass, Carolin Loos, Elba Raimúndez-Álvarez, et al.
Epidemics|February 8, 2021
COVID-19 outbreak in Wuhan demonstrates the limitations of publicly available case numbers for epidemiological modelingElba Raimúndez, Erika Dudkin, Jakob Vanhoefer, et al.
Plos Computational Biology|March 3, 2020
Model-based analysis of response and resistance factors of cetuximab treatment in gastric cancer cell linesElba Raimúndez, Simone Keller, Gwen Zwingenberger, et al.
BMC Cancer|November 23, 2020
Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell linesKarolin Ebert, Gwen Zwingenberger, Elena Barbaria, et al.
BMC Cancer|October 29, 2020
Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell linesKarolin Ebert, Gwen Zwingenberger, Elena Barbaria, et al.
Epidemics|March 17, 2023
Integrative modelling of reported case numbers and seroprevalence reveals time-dependent test efficiency and infectious contactsLorenzo Contento, Noemi Castelletti, Elba Raimúndez, et al.
BMC Cancer|March 10, 2022
Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies-the role of HAS2, SHB and HBEGFKarolin Ebert, Ivonne Haffner, Gwen Zwingenberger, et al.
Bioinformatics (Oxford, England)|November 23, 2023
pyPESTO: a modular and scalable tool for parameter estimation for dynamic modelsYannik Schälte, Fabian Fröhlich, Paul J Jost, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2021
HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ StudyIvonne Haffner, Katrin Schierle, Elba Raimúndez, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Iscience|October 23, 2023
Posterior marginalization accelerates Bayesian inference for dynamical models of biological processesElba Raimúndez, Michael Fedders, Jan Hasenauer
Bioinformatics (Oxford, England)|January 10, 2019
Benchmark problems for dynamic modeling of intracellular processesHelge Hass, Carolin Loos, Elba Raimúndez-Álvarez, et al.
Epidemics|February 8, 2021
COVID-19 outbreak in Wuhan demonstrates the limitations of publicly available case numbers for epidemiological modelingElba Raimúndez, Erika Dudkin, Jakob Vanhoefer, et al.
Plos Computational Biology|March 3, 2020
Model-based analysis of response and resistance factors of cetuximab treatment in gastric cancer cell linesElba Raimúndez, Simone Keller, Gwen Zwingenberger, et al.
BMC Cancer|November 23, 2020
Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell linesKarolin Ebert, Gwen Zwingenberger, Elena Barbaria, et al.
BMC Cancer|October 29, 2020
Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell linesKarolin Ebert, Gwen Zwingenberger, Elena Barbaria, et al.
Epidemics|March 17, 2023
Integrative modelling of reported case numbers and seroprevalence reveals time-dependent test efficiency and infectious contactsLorenzo Contento, Noemi Castelletti, Elba Raimúndez, et al.
BMC Cancer|March 10, 2022
Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies-the role of HAS2, SHB and HBEGFKarolin Ebert, Ivonne Haffner, Gwen Zwingenberger, et al.
Bioinformatics (Oxford, England)|November 23, 2023
pyPESTO: a modular and scalable tool for parameter estimation for dynamic modelsYannik Schälte, Fabian Fröhlich, Paul J Jost, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2021
HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ StudyIvonne Haffner, Katrin Schierle, Elba Raimúndez, et al.
Pageof 2